Showing results (11-20 of 164) with videos related to
Sort By:
Pageof 17
Journal of Clinical Pharmacology|July 28, 2018
Pharmacometabolomics Reveals Irinotecan Mechanism of Action in Cancer PatientsXun Bao, Jianmei Wu, Seongho Kim, et al.Cancer Chemotherapy and Pharmacology|May 10, 2014
Results of a phase 1, randomized study evaluating the effects of food and diurnal variation on the pharmacokinetics of linifanibHao Xiong, Yi-Lin Chiu, Justin L Ricker, et al.Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|June 20, 2016
An aqueous normal-phase chromatography coupled with tandem mass spectrometry method for determining unbound brain-to-plasma concentration ratio of AZD1775, a Wee1 kinase inhibitor, in patients with glioblastomaJianmei Wu, Nader Sanai, Xun Bao, et al.Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|March 14, 2012
Simultaneous determination of 1-(2'-deoxy-2'-fluoro-β-D-arabinofuranosyl) uracil (FAU) and 1-(2'-deoxy-2'-fluoro-β-D-arabinofuranosyl) 5-methyluracil (FMAU) in human plasma by liquid chromatography/tandem mass spectrometryRichard Wiegand, Jianmei Wu, Anthony F Shields, et al.Journal of the American Academy of Dermatology|January 17, 2015
Cutaneous adverse effects of targeted therapies: Part I: Inhibitors of the cellular membraneJames B Macdonald, Brooke Macdonald, Loren E Golitz, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 21, 2014
Complex disease-, gene-, and drug-drug interactions: impacts of renal function, CYP2D6 phenotype, and OCT2 activity on veliparib pharmacokineticsJing Li, Seongho Kim, Xianyi Sha, et al.Molecular Cancer Therapeutics|August 18, 2010
Association of human cytochrome P450 1A1 (CYP1A1) and sulfotransferase 1A1 (SULT1A1) polymorphisms with differential metabolism and cytotoxicity of aminoflavoneQiang Zheng, Xianyi Sha, Jiansheng Liu, et al.Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|April 8, 2009
Validation and implementation of a liquid chromatography/tandem mass spectrometry assay to quantitate aminoflavone (NSC 686288) in human plasmaRichard Wiegand, Jianmei Wu, Xianyi Sha, et al.Journal of the American Academy of Dermatology|January 17, 2015
Cutaneous adverse effects of targeted therapies: Part II: Inhibitors of intracellular molecular signaling pathwaysJames B Macdonald, Brooke Macdonald, Loren E Golitz, et al.American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 14, 2026
Advancing Antibody-Drug Conjugates: Current Perspectives and Future DirectionsJulian David Etessami, Carmine Valenza, Anthony W Tolcher, et al.Pageof 17